Schizophrenia an Alzheimer are dreadful mental illnesses. More than 65 million, according to rough estimate by various agencies, people are afflicted of these two diseases, but there is hardly any treatment so far.
N-methyl-d-aspartate receptor (NMDAR) , a new compound, has raised the hope of scientists to find a cure .
After decades of research, scientists have found that this compound plays a critical role in improving the learning process.
This is largely responsible for the signaling process among neurons.
Researchers have found that by boosting the signaling process in the brain can strengthen the connections between our neurons—which may improve the learning process in the human brain. It can further pay the way for the treament of Schizophrenia.
The research has been carried out by the team of Robert F. Asarnow at UCLA who found that the compound d-cycloserine, when given to people, showed greater activity spikes than those who had not been given.
The results are exciting, says Stefan G. Hofmann of Boston University. This is the first evidence that d-cycloserine can enhance forms of cognition relevant to some psychiatric disorders, he says.